Oncopeptides Offers Virtual Webcast: The African American Experience in Multiple Myeloma

Multiple Myeloma is the 2nd most common blood cancer (Cancer Facts & Figures 2020), accounting for about 1.8% of all cancers (SEER Cancer Stat Facts: Myeloma) and is the leading hematologic cancer in African Americans (Pierre and Williams. Clin J Oncol Nursing. 2020;24:439-443). An estimated 32,000 patients were diagnosed with multiple myeloma in the United States in 2020 (SEER Cancer Stat Facts: Myeloma), with 20% of those being African American (Pierre and Williams. Clin J Oncol Nursing. 2020;24:439-443). Because multiple myeloma disproportionately affects the African American population, Oncopeptides is hosting a discussion with experts in the fields of Multiple Myeloma and Diversity and Equity in Health Care.

You are cordially invited to join Oncopeptides for a Virtual Webcast titled “African American Experience in Multiple Myeloma” taking place on May 13, 2021 from 3-4 pm PDT/6-7 pm EDT.

This presentation will feature a panel of experts discussing key data around the African American Experience in Multiple Myeloma and strategies to remove disparities and barriers to care, followed by a Q&A session.

To confirm your participation and receive further updates, please complete your registration by CLICKING HERE.



No comments have been posted yet.